Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.

UNLABELLED The aim of this study was to compare the visual analysis of attenuation-corrected and noncorrected 18F-fluoro-2-deoxy-D-glucose (FDG) PET images in patients with primary or metastatic breast cancer using standardized film documentation and to evaluate the influence of attenuation correction on lesion detectability. METHODS Standard FDG PET of the breasts and of the axillary regions was performed on 28 women with breast cancer. Transmission scans were acquired for attenuation correction after administration of FDG. Transverse and coronal slices and maximum intensity projections both with and without attenuation correction were documented in a standardized manner on film. Noncorrected images were displayed with an upper threshold of five times the mean activity in normal lung tissue. Attenuation-corrected images were documented with an upper threshold of a standardized uptake value of five. Two independent nuclear medicine physicians, who were unaware of the results of clinical investigation, other imaging modalities and histopathologic findings, interpreted the images visually, noncorrected images first. RESULTS One hundred eighty-four of 189 lesions in 28 of 28 patients were found on attenuation-corrected and noncorrected images. Seventeen lesions were found in the breasts of 12 patients. In 18 patients, 31 axillary lesions were found. Moreover, 141 lesions representing distant metastases were detected in 18 patients. Attenuation-corrected images showed the same lesions in all patients but 2, in whom 5 of 189 small pulmonary lesions (2.6%) were not detected. Iterative reconstruction did not improve detectability of these lesions on attenuation-corrected images. These lesions were confirmed by CT, which revealed diameters of <1 cm. CONCLUSION Attenuation correction by transmission measurement after injection may impair lesion detectability in PET for staging of breast cancer patients. When using the image modalities described, noncorrected PET images should be considered in image analysis.

[1]  E. Hoffman,et al.  Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. , 1979, Journal of computer assisted tomography.

[2]  S Grootoonk,et al.  Performance Evaluation of the Positron Scanner ECAT EXACT , 1992, Journal of computer assisted tomography.

[3]  B F Hutton,et al.  Accelerated EM reconstruction in total-body PET: potential for improving tumour detectability. , 1994, Physics in medicine and biology.

[4]  David J. Yang,et al.  Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M. Ito,et al.  Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography. , 1989, Journal of computer assisted tomography.

[6]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[7]  G. P. Krestin,et al.  Detection of breast cancer with conventional mammography and contrast-enhanced MR imaging , 1998, European Radiology.

[8]  L Watson.  The role of ultrasound in breast imaging. , 2000, Radiologic technology.

[9]  R L Wahl,et al.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1991, Radiology.

[10]  D. Noh,et al.  Diagnostic Value of Positron Emission Tomography for Detecting Breast Cancer , 1998, World Journal of Surgery.

[11]  R L Wahl,et al.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Malcolm Hudson,et al.  Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.

[13]  G. Hortobagyi,et al.  Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer , 1993, Cancer.

[14]  R. Egan,et al.  Detection of breast carcinoma: comparison of automated water-path whole-breast sonography, mammography, and physical examination. , 1984, AJR. American journal of roentgenology.

[15]  M. Daube-Witherspoon,et al.  A method for postinjection PET transmission measurements with a rotating source. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Overview of the current status of PET in breast cancer imaging. , 1998 .

[17]  G Hermann,et al.  Nonpalpable breast lesions: accuracy of prebiopsy mammographic diagnosis. , 1987, Radiology.

[18]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[19]  R. Buchert,et al.  Onco-PET: Lesion Detection by Computer Display versus Standardized Documentation on Film , 1999 .

[20]  H. Minn,et al.  [18F]Fluorodeoxyglucose Uptake in Tumors: Kinetic vs. Steady‐State Methods with Reference to Plasma Insulin , 1993, Journal of computer assisted tomography.

[21]  W. J. Lorenz,et al.  Measured attenuation correction methods , 2004, European Journal of Nuclear Medicine.

[22]  J. Bergh,et al.  Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.